Popular Hemp

Opioid Bods At Purdue & Frends Want Cannabis Administration and Opportunity Act To Cap THC

Business Of Cannabis reports on people, companies and organisations that have no concept of shame

Anti-drug coalition funded by Purdue Pharma opposes the CAOA

The Community Anti-Drug Coalitions of America (CADCA) is asking supporters to write to Senators to oppose the recently introduced Cannabis Administration and Opportunity Act on the basis that the legislation doesn’t cap THC levels on products or require packaging to include warning labels, among other issues.

“Research on marijuana shows that it is contraindicated for fetal and adolescent brain development and is linked to attention, memory, motivation and learning problems in youth,” says the organization’s website, citing the opioid epidemic’s ongoing challenges. “Marijuana use is also linked to negative health and societal outcomes, such as increased workplace injuries, increased fatal car accidents, physical ailments, and serious mental health issues.”

Dr. Peter Greenspoon, a well-known cannabis advocate, noted that the organization is supported by a long list of corporate sponsors, including pharmaceutical companies such as Purdue Pharma, which paid out USD $6 billion in settlements for its role in the opioid crisis. Other sponsors include banks, consulting firms and the NFL.

Anti-drug coalition funded by Purdue Pharma opposes the CAOA

0 thoughts on “Opioid Bods At Purdue & Frends Want Cannabis Administration and Opportunity Act To Cap THC”

Write a Reply or Comment

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.